Alphabet’s new CFO was in the middle of the GLP-1 boom. Now she’s onto generative AI
Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli LillyEli LillyAlphabet's outgoing finance chief, Ruth Porat, spent the ...
Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli LillyEli LillyAlphabet's outgoing finance chief, Ruth Porat, spent the ...
A view of Google Headquarters in Mountain View, California, United States on April 16, 2024. Tayfun Coskun | Anadolu | Getty ...
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in ...
The FDA has approved Moderna's RSV vaccine for older adults.Courtesy: ModernaThe Food and Drug Administration on Friday approved Moderna's vaccine ...
With an expected earnings growth of 15%, domestic brokerage firm Emkay Investment Managers expects Nifty to reach 24,500 by December ...
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments' GLP-1 & Weight ...
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan ...
Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas.Brandon Bell | Getty ImagesU.S. health officials ...
A vial labeled "Novavax V Covid-19 Vaccine" is seen in this photo taken Jan. 16, 2022.Dado Ruvic | ReutersShares of ...
Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. Mike Blake ...
© 2024 LSD News title="Jegtheme">Jegtheme.